Skip to content
Recall Observatory FDA recall evidence

Exact FDA event identifier

Event 66511

1 recalled-product record grouped only because every row carries this exact official event ID.

Open FDA event record

Event summary

Timeline bucket
October 11, 2013
Product types
Food
Classifications
Class II
Statuses
Terminated
Recalling firm wording
Metagenics, Inc.

Dossier provenance

Source snapshots represented here

  • openFDA Food Enforcement Report-date coverage June 20, 2012–July 08, 2026 Known gap: openFDA describes 2004-present coverage, but the current export has no report-date records in this interval.

Enforcement coverage uses report dates; product initiation dates can precede those bounds. Device-enrichment coverage uses FDA event_date_initiated.

How coverage and grouping work

Complete imported group

Every recalled product in this event

1 official enforcement rows

Product dates, classifications, firms, and source wording remain attached to their individual rows. Opening this dossier never hides products that did not match a prior timeline filter.

food · product 1 of 1

Spectrazyme, 180 count, 60 count, 12 bottles/case, 20000 tablets/box, 14000 capsules/pail.

F-0138-2014
Recall number
F-0138-2014
Initiated
October 11, 2013
Classification
Class II
Status
Terminated
Recalling firm
Metagenics, Inc.
Quantity
1,171,300 units

App-derived interpretation

Unknown reason.no_named_rule · v1.0.0
Metagenics is recalling Spectrazyme because their raw material supplier informed them that enzymes in the blend may contain the antibiotic chloramphenicol.

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Metagenics is recalling Spectrazyme because their raw material supplier informed them that enzymes in the blend may contain the antibiotic chloramphenicol.

Code information

Lot Code: 0413083 0513007 0513008

Distribution pattern

Nationwide in US and worldwide to Japan, Taiwan, Belgium, and Canada